Posts Tagged Business Development/Sales

Up and Away, M&A

by

Mergers and acquisitions are positive for the CDMO industry, but there is a downside. Mergers and acquisitions (M&A) are a central feature of the contract development and manufacturing (CDMO) industry today. Several new deals are being announced every month, some of them quite substantial, and these deals are reshaping the industry. CDMOs are in great […]

Learn more

CMOs Must Embrace Flexible Manufacturing

by

The need for flexibility in manufacturing arrangements and technologies has never been greater. New products are more technically challenging, produced in smaller volumes, and subject to great market uncertainty stemming from competing therapies and reimbursement risk. Contract development and manufacturing organizations (CDMOs) need to respond in both technical capabilities and business model flexibility to address […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on CymaBay Therapeutics

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. CymaBay Therapeutics, formerly known as Metabolex, develops drugs to treat diabetes and related metabolic disorders. It plans to raise $84.5 million in a secondary public […]

Learn more

Contacts Are Where It’s At

by

The true purpose of the PharmSource Lead Sheet is to keep you abreast of any event that would create an opportunity for a service or product provider in the drug, device or diagnostic development arena. In order to create this weekly business development tool we track drugs from discovery through to marketed, alert you to […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on AveXis, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. AveXis, Inc., develops gene therapies for the treatment of rare and orphan neurological genetic diseases. It plans to raise $234.5 million in a secondary public […]

Learn more

Follow the Money to Medical Devices & Diagnostics
Spotlight on Titan Medical, Inc.

by

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Titan Medical, Inc. is a public company based in Canada that designs and develops robotic surgical systems for applications […]

Learn more

PharmSource Coverage of ASCO 2017

by

Chicago hosted 30,000 American Society of Clinical Oncology (ASCO) conference visitors this weekend, including myself and fellow researcher Scotty Chung-Siu. You may have noticed the uptick in the PharmSource Lead Sheet recently, especially in Phase I & II studies. In fact, oncology leads hold 46% of this week’s PharmSource Lead Sheet, so be sure to […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on AmpliPhi Biosciences Corporation

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. AmpliPhi Biosciences, (formerly known as Targeted Genetics Corporation), develops gene-based products for the treatment of acquired and inherited diseases. It raised $9.1 million in a […]

Learn more

Follow the Money to Medical Devices & Diagnostics
Spotlight on CartiHeal Ltd.

by

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. CartiHeal Ltd. is a private company based in Israel that develops cell-free cartilage regeneration technology. It raised $18.3 million […]

Learn more